Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
Charles W. Schindler, Godfrey H. Redhi, Kiran Vemuri, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 9, pp. 2283-2293
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua, Kiran Vemuri, Mengchen Pu, et al.
Cell (2016) Vol. 167, Iss. 3, pp. 750-762.e14
Open Access | Times Cited: 617
Cannabis use and cannabis use disorder
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 300
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats
Timothy G. Freels, Lydia N. Baxter-Potter, Janelle M. Lugo, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 9, pp. 1897-1908
Open Access | Times Cited: 103
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Matthew E. Sloan, Joshua L. Gowin, Vijay A. Ramchandani, et al.
Neuropharmacology (2017) Vol. 124, pp. 73-83
Closed Access | Times Cited: 85
Neural Substrates and Circuits of Drug Addiction
Matthew W. Feltenstein, Ronald E. See, Rita A. Fuchs
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 4, pp. a039628-a039628
Open Access | Times Cited: 50
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
Kari A. Johnson, David M. Lovinger
Frontiers in Cellular Neuroscience (2016) Vol. 10
Open Access | Times Cited: 58
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats
Foteini Delis, Alexia Polissidis, Nafsika Poulia, et al.
The International Journal of Neuropsychopharmacology (2016), pp. pyw102-pyw102
Open Access | Times Cited: 48
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
Christina A. Brust, Matthew A. Swanson, Laura Bohn
Biochemical Society Transactions (2023) Vol. 51, Iss. 4, pp. 1533-1543
Open Access | Times Cited: 13
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Cristina Aparecida Jark Stern, Cristiane Ribeiro de Carvalho, Leandro J. Bertoglio, et al.
Neuroscience (2017) Vol. 370, pp. 62-80
Closed Access | Times Cited: 48
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xianghu He, Chloe J. Jordan, Kiran Vemuri, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 365-373
Open Access | Times Cited: 46
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling
Andrea Balla, Bin Dong, B. M. Shilpa, et al.
Neuropharmacology (2017) Vol. 131, pp. 200-208
Open Access | Times Cited: 41
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Matthew E. Sloan, Caroline W. Grant, Joshua L. Gowin, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 342-350
Open Access | Times Cited: 41
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Analysis of natural product regulation of opioid receptors in the treatment of human disease
Simone Badal, Sophie C. Turfus, Rajendram V. Rajnarayanan, et al.
Pharmacology & Therapeutics (2017) Vol. 184, pp. 51-80
Closed Access | Times Cited: 35
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure
Leigh V. Panlilio, Zuzana Justinová
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 116-141
Open Access | Times Cited: 34
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Omar Soler‐Cedeño, Zheng‐Xiong Xi
Cells (2022) Vol. 11, Iss. 20, pp. 3262-3262
Open Access | Times Cited: 16
Adult consequences of repeated nicotine and Δ9-tetrahydrocannabinol (THC) vapor inhalation in adolescent rats
Arnold Gutierrez, Kevin M. Creehan, Yanabel Grant, et al.
Psychopharmacology (2024) Vol. 241, Iss. 3, pp. 585-599
Open Access | Times Cited: 3
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
Omar Soler‐Cedeño, Hannah Alton, Guo‐Hua Bi, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1678-1688
Open Access | Times Cited: 3
Psychosocial and pharmacological interventions for the treatment of cannabis use disorder
Pamela Sabioni, Bernard Le Foll
F1000Research (2018) Vol. 7, pp. 173-173
Open Access | Times Cited: 28
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Heath D. Schmidt, Laura E. Rupprecht, Nii Addy
Complex Psychiatry (2018) Vol. 4, Iss. 4, pp. 169-189
Open Access | Times Cited: 25
Neurobiology of Stress-Induced Nicotine Relapse
Xinyu Wang, Yun Chen, Jing Dong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1482-1482
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top